Committee Member

12:45pm–1:30pm

Lunch

1:30pm–1:45pm

Overview of the IPTi Consortium

Pedro Alonso, M.D., Ph.D.

Director, Barcelona Centre for International Health Research at the Hospital Clinic and Professor at the University of Barcelona

1:45pm–2:15pm

Pooled Efficacy of Intermittent Preventive Treatment for Malaria in Infants with Sulfadoxine-Pyrimethamine (IPTi-SP)

John Aponte, M.D., M.Sc.

Research Professor and Head, Statistics Unit of the Barcelona Centre for International Health Research (CRESIB)

2:15pm–2:30pm

Break

2:30pm–4:30pm

Acceptability, Cost-Effectiveness, Drug Resistance, Applicability of IPTi-SP, Effectiveness Study of IPTi-SP (five presentations)

David Schellenberg, M.B.B.S., D.T.M.H., M.R.C.P., Ph.D.

Professor, Malaria and International Health, London School of Hygiene and Tropical Medicine

4:30pm–5:10pm

United Nations Children’s Fund (UNICEF) Pilot Implementation of IPTi-SP

Alexandra de Sousa, M.D., Ph.D.

Operational Research Coordinator, Unit of Policy and Evidence, UNICEF

5:10pm–5:30pm

IPTi Consortium Policy Process

Andrea Egan, Ph.D.

Coordinator, IPTi Consortium

5:30pm–5:40pm

Concluding Remarks, Questions, Public Announcement of Change to Next Day’s Schedule with WHO Speaker Starting at 8:15am.

Myron M. Levine, M.D., D.T.P.H.

IOM Committee Chair

Thursday, January 10, 2008—APHA Conference Room A

OPEN SESSION

8:15am–9:00am

World Health Organization’s Global Malaria Program: Considerations of IPTi-SP Within Context of Malaria Control Program

Dr. Peter Olumese, M.B., FMCPaed

Case Management and Research Team, Global



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement